EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma

Association of Phosphorylated Epidermal Growth Factor Receptor with Survival in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Radiotherapy

(2010) Theodoros Tsakiridis et al.   Journal of Thoracic Oncology

The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer

(2008) P de Graeff et al.   BRITISH JOURNAL OF CANCER

Molecular imaging of epidermal growth factor receptor expression–activity at the kinase level in tumors with positron emission tomography

(2008) Juri G. Gelovani   CANCER AND METASTASIS REVIEWS

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via  5-Integrin, which Is a Therapeutic Target

(2008) K. Sawada et al.   CANCER RESEARCH

Matrix Metalloproteinase 9 Is a Mediator of Epidermal Growth Factor-Dependent E-Cadherin Loss in Ovarian Carcinoma Cells

(2008) K. D. Cowden Dahl et al.   CANCER RESEARCH

Membrane-anchored growth factors, the epidermal growth factor family: Beyond receptor ligands

(2008) Shigeki Higashiyama et al.   CANCER SCIENCE

The epidermal growth factor receptor family: Biology driving targeted therapeutics

(2008) M. J. Wieduwilt et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer

(2008) A. Mustea et al.   CYTOKINE

Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: High level expression in clear cell carcinoma

(2008) Brian P. Adley et al.   GYNECOLOGIC ONCOLOGY

The emerging role of epidermal growth factor receptor inhibitors in ovarian cancer

(2008) M.J. PALAYEKAR et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Matrix Metalloproteinase-9 Associated with Heparan Sulphate Chains of GPI-Anchored Cell Surface Proteoglycans Mediates Motility of Murine Colon Adenocarcinoma Cells

(2008) Y. Koyama et al.   JOURNAL OF BIOCHEMISTRY

Visualization of Polarized Membrane Type 1 Matrix Metalloproteinase Activity in Live Cells by Fluorescence Resonance Energy Transfer Imaging

(2008) Mingxing Ouyang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin

(2008) Hilary A. Kenny et al.   JOURNAL OF CLINICAL INVESTIGATION

Determinants ofRASistance to Anti–Epidermal Growth Factor Receptor Agents

(2008) José Baselga et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer

(2008) Ajay P Singh et al.   LANCET ONCOLOGY

Vascular Endothelial Growth Factor Stimulates Organ-Specific Host Matrix Metalloproteinase-9 Expression and Ovarian Cancer Invasion

(2008) D. Belotti et al.   MOLECULAR CANCER RESEARCH

Heparin-binding epidermal growth factor–like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition

(2008) Hiroshi Yagi et al.   MOLECULAR CANCER THERAPEUTICS

EGFR Antagonists in Cancer Treatment

(2008) Fortunato Ciardiello et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Promise and Perils of ‘Targeted Therapy’ of Advanced Ovarian Cancer

(2008) Maurie Markman   ONCOLOGY

Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications

(2008) Giampaolo Tortora et al.   Nature clinical practice. Oncology

Metastasis: a therapeutic target for cancer

(2008) Patricia S Steeg et al.   Nature clinical practice. Oncology

Crosstalk between G-protein-coupled receptors and Epidermal growth factor receptor in cancer

(2007) Neil et al.   Frontiers in Bioscience-Landmark

A Proteome Resource of Ovarian Cancer Ascites: Integrated Proteomic and Bioinformatic Analyses To Identify Putative Biomarkers

(2007) Limor Gortzak-Uzan et al.   JOURNAL OF PROTEOME RESEARCH

MMPs as therapeutic targets—Still a viable option?

(2007) B FINGLETON   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY